OkuStim® 2
OkuStim® 2 was developed for the simple and safe self-application of transcorneal electrical stimulation. Patients can quickly learn how to use the device and carry out their therapy independently at home, once a week for 30 minutes.
Okuvision GmbH
2O19
Informationen über das Unternehmen
Okuvision is a leading provider in the field of transcorneal electrical stimulation. OkuStim® therapy can slow down the progression of visual field loss in patients with retinitis
pigmentosa. This can delay the onset of serious limitations caused by vision loss.
Kontaktangaben
Okuvision GmbH
Gerhard-Kindler-Straße 17
72770 Reutlingen
Germany
Tel: +49 7121159350
Note
The exhibitor is solely responsible for the content of the exhibitor presentation both on the organizer’s website and on the website of the respective exhibitor. The organizer assumes no responsibility or liability whatsoever.